{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:29:18Z","timestamp":1774686558811,"version":"3.50.1"},"reference-count":12,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"abstract":"<jats:p>Evaluation of hypoglycemia in a patient with known diabetes mellitus, although usually straightforward, can at times be challenging. We present the case of an 8 year-old Latina girl initially diagnosed with type 1 diabetes mellitus in the setting of multiple autoimmune disorders, including dermatomyositis and lupus nephritis. She subsequently developed signs of insulin resistance and severe hypoglycemia, which was found to be due to insulin-receptor autoantibodies. This condition, known as type B insulin resistance, is a rare, heterogeneous metabolic disease that may feature hypoglycemia in the setting of extreme insulin resistance and hyperinsulinemia and, in this case, masqueraded as type 1 diabetes mellitus. The presence of hypoglycemia in the setting of multiple autoimmune disorders should prompt consideration of autoimmune-mediated hypoglycemia. In addition to immunologic modifying therapies, advances in diabetes care in the form of continuous glucose monitoring have provided an additional tool to manage recurrent hypoglycemia.<\/jats:p>","DOI":"10.1542\/peds.2016-0866","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T11:48:59Z","timestamp":1494589739000},"source":"Crossref","is-referenced-by-count":6,"title":["Intractable Hypoglycemia in the Setting of Autoimmune Overlap Syndrome"],"prefix":"10.1542","volume":"139","author":[{"given":"Kanika","family":"Shanker","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanicia","family":"Daley","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Semple","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Rouster-Stevens","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Department of Pediatrics, Emory University, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Nina","family":"Ham","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"issue":"3","key":"2021120916500038700_B1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MD.0b013e3181a5b42e","article-title":"Autoimmune forms of hypoglycemia.","volume":"88","author":"Lupsa","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2021120916500038700_B2","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1210\/jc.2010-0167","article-title":"Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.","volume":"95","author":"Malek","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2021120916500038700_B3","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.bbmt.2014.06.032","article-title":"Bortezomib for refractory autoimmunity in pediatrics.","volume":"20","author":"Khandelwal","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2021120916500038700_B4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/jcp.54.5.340","article-title":"Autoantibodies and overlap syndromes in autoimmune rheumatic disease.","volume":"54","author":"Jury","year":"2001","journal-title":"J Clin Pathol"},{"issue":"2","key":"2021120916500038700_B5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-102-2-176","article-title":"Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors.","volume":"102","author":"Tsokos","year":"1985","journal-title":"Ann Intern Med"},{"issue":"2","key":"2021120916500038700_B6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2021120916500038700_B7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI111032","article-title":"Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats.","volume":"72","author":"Dons","year":"1983","journal-title":"J Clin Invest"},{"issue":"2","key":"2021120916500038700_B8","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2337\/dc11-1967","article-title":"Association of type B insulin resistance and type 1 diabetes resulting in ketoacidosis.","volume":"35","author":"Bourron","year":"2012","journal-title":"Diabetes Care"},{"key":"2021120916500038700_B9","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","article-title":"Classification and diagnosis of diabetes [published correction appears in Diabetes Care. 2016;39(9):1653].","volume":"39","author":"American Diabetes Association","year":"2016","journal-title":"Diabetes Care"},{"issue":"5","key":"2021120916500038700_B10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance.","volume":"31","author":"Semple","year":"2008","journal-title":"Diabetes Care"},{"issue":"6","key":"2021120916500038700_B11","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/db06-1665","article-title":"Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies.","volume":"56","author":"Semple","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"2021120916500038700_B12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJMoa1314474","article-title":"Outpatient glycemic control with a bionic pancreas in type 1 diabetes.","volume":"371","author":"Russell","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0866\/1064133\/peds_20160866.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-0866\/1064133\/peds_20160866.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T14:43:19Z","timestamp":1659019399000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/139\/6\/e20160866\/38793\/Intractable-Hypoglycemia-in-the-Setting-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-0866","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]},"article-number":"e20160866"}}